Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Protagonist Therapeutics Inc | 785,655 | 1,603,932 | +818,277 | $22.73M | $55.58M | 11.19% | +$32.85M |
| Cytokinetics, Incorporated(CYTK) | 319,510 | 853,862 | +534,352 | $22.40M | $46.26M | 9.32% | +$23.86M |
| Roivant Sciences Ltd.SHS(ROIV) | 2,791,870 | 4,150,009 | +1,358,139 | $29.43M | $43.87M | 8.83% | +$14.44M |
| Ea Series TrustALPHA ARCH 1 3 ALPHA ARCH 1-3 | 318,120 | 351,482 | +33,362 | $33.87M | $37.90M | 7.63% | +$4.03M |
| BridgeBio Pharma, Inc.(BBIO) | 549,804 | 1,264,570 | +714,766 | $17.00M | $32.03M | 6.45% | +$15.03M |
| Royalty Pharma plcCL A(RPRX) | 721,301 | 1,181,332 | +460,031 | $21.91M | $31.15M | 6.27% | +$9.25M |
| Keros Therapeutics, Inc.(KROS) | 338,243 | 548,916 | +210,673 | $22.39M | $25.09M | 5.05% | +$2.69M |
| Immunovant, Inc.(IMVT) | 60,763 | 476,543 | +415,780 | $1.96M | $12.58M | 2.53% | +$10.62M |
| Arbutus Biopharma Corporation(ABUS) | 2,074,183 | 3,289,260 | +1,215,077 | $5.35M | $10.16M | 2.05% | +$4.81M |
| Merck & Co., Inc.(MRK) | 300 | 75,750 | +75,450 | $39.6K | $9.38M | 1.89% | +$9.34M |
| Rezolute, Inc.(RZLT) | 0 | 2,063,962 | +2,063,962 | $0 | $8.88M | 1.79% | +$8.88M |
| Solid Biosciences Inc | 203,204 | 1,420,422 | +1,217,218 | $2.71M | $8.05M | 1.62% | +$5.35M |
| Edgewise Therapeutics, Inc.(EWTX) | 180,911 | 436,608 | +255,697 | $3.30M | $7.86M | 1.58% | +$4.56M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 0 | 750,000 | +750,000 | $0 | $7.54M | 1.52% | +$7.54M |
| Ascendis Pharma A/SADR(ASND) | 48,584 | 51,263 | +2,679 | $7.34M | $6.99M | 1.41% | -$353.2K |
| Tectonic Therapeutic, Inc.(TECX) | 0 | 356,878 | +356,878 | $0 | $5.88M | 1.18% | +$5.88M |
| uniQure N.V.SHS(QURE) | 292,850 | 1,222,676 | +929,826 | $1.52M | $5.48M | 1.10% | +$3.95M |
| Absci Corporation | 586,984 | 1,698,529 | +1,111,545 | $3.33M | $5.23M | 1.05% | +$1.90M |
| Viking Therapeutics, Inc.(VKTX) | 14,401 | 91,227 | +76,826 | $1.18M | $4.84M | 0.97% | +$3.66M |
| Alkermes plcSHS(ALKS) | 156,600 | 196,577 | +39,977 | $4.24M | $4.74M | 0.95% | +$498.3K |
| Helix Acquisition Corp IiCL A | 403,500 | 404,138 | +638 | $4.20M | $4.13M | 0.83% | -$66.1K |
| Anaptysbio Inc | 1,000 | 155,799 | +154,799 | $22.5K | $3.90M | 0.79% | +$3.88M |
| Cerevel Therapeutics Hldng I | 24,259 | 93,350 | +69,091 | $1.03M | $3.82M | 0.77% | +$2.79M |
| Crinetics Pharmaceuticals In | 0 | 74,850 | +74,850 | $0 | $3.35M | 0.68% | +$3.35M |
| Spdr Ser TrBLOOMBERG 1 3 MO ST STR BLO 1 ETF | 32,500 | 32,500 | 0 | $2.98M | $2.98M | 0.60% | -$650 |
| Insmed Incorporated(INSM) | 0 | 42,217 | +42,217 | $0 | $2.83M | 0.57% | +$2.83M |
| Q32 Bio Inc.(QTTB) | 187,567 | 156,504 | -31,063 | $3.20M | $2.81M | 0.57% | -$386.9K |
| Acasti Pharma IncCL A | 217,381 | 959,571 | +742,190 | $744.5K | $2.80M | 0.56% | +$2.06M |
| Vanguard Bd Index FdsVANGUARD ULTRA VANGUARD ULTRA | 55,206 | 55,206 | 0 | $2.74M | $2.73M | 0.55% | -$1.7K |
| J P Morgan Exchange Traded FULTRA SHRT INC ULTRA SHRT ETF | 54,000 | 54,000 | 0 | $2.72M | $2.73M | 0.55% | +$1.1K |
| Ishares TrSHORT TREAS BD | 24,500 | 24,500 | 0 | $2.71M | $2.71M | 0.55% | -$980 |
| Savara Inc.(SVRA) | 5,600 | 663,598 | +657,998 | $27.9K | $2.67M | 0.54% | +$2.65M |
| OmniAb, Inc.(OABI) | 451,485 | 712,560 | +261,075 | $2.45M | $2.67M | 0.54% | +$225.1K |
| WisdomTree, Inc.FLOATNG RAT TREA(WT) | 53,000 | 53,000 | 0 | $2.67M | $2.67M | 0.54% | +$1.1K |
| Achieve Life Sciences Inc | 875,000 | 542,233 | -332,767 | $3.98M | $2.55M | 0.51% | -$1.43M |
| Centessa Pharmaceuticals PlcADS | 206,856 | 253,197 | +46,341 | $2.34M | $2.29M | 0.46% | -$51.1K |
| Fulcrum Therapeutics, Inc.(FULC) | 339,825 | 368,369 | +28,544 | $3.21M | $2.28M | 0.46% | -$924.1K |
| KALA BIO, Inc.(KALA) | 0 | 306,067 | +306,067 | $0 | $2.17M | 0.44% | +$2.17M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 114,309 | +114,309 | $0 | $2.13M | 0.43% | +$2.13M |
| Ssga Active Etf TrULT SHT TRM BD ST STR UL BD ETF | 47,684 | 47,684 | 0 | $1.93M | $1.93M | 0.39% | -$1.4K |
| Beam Therapeutics Inc.(BEAM) | 0 | 72,800 | +72,800 | $0 | $1.71M | 0.34% | +$1.71M |
| Cellectar Biosciences, Inc.(CLRB) | 642,541 | 682,094 | +39,553 | $2.56M | $1.71M | 0.34% | -$852.1K |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 101,626 | 103,121 | +1,495 | $1.43M | $1.68M | 0.34% | +$241.8K |
| Delcath Systems, Inc.(DCTH) | 218,973 | 198,347 | -20,626 | $1.04M | $1.66M | 0.33% | +$615.7K |
| Soleno Therapeutics Inc | 0 | 39,929 | +39,929 | $0 | $1.63M | 0.33% | +$1.63M |
| Apogee Therapeutics Inc | 6,000 | 40,875 | +34,875 | $398.7K | $1.61M | 0.32% | +$1.21M |
| Merus N V | 0 | 26,850 | +26,850 | $0 | $1.59M | 0.32% | +$1.59M |
| BeOne Medicines AGADR(ONC) | 31,505 | 11,100 | -20,405 | $4.93M | $1.58M | 0.32% | -$3.34M |
| Aura Biosciences, Inc.(AURA) | 0 | 203,237 | +203,237 | $0 | $1.54M | 0.31% | +$1.54M |
| Kymera Therapeutics, Inc.(KYMR) | 16,000 | 50,626 | +34,626 | $643.2K | $1.51M | 0.30% | +$868.0K |
| Applied Therapeutics Inc | 456,588 | 320,727 | -135,861 | $3.10M | $1.50M | 0.30% | -$1.61M |
| Context Therapeutics Inc.(CNTX) | 205,934 | 645,161 | +439,227 | $284.2K | $1.29M | 0.26% | +$1.01M |
| Astria Therapeutics Inc | 4,652 | 138,158 | +133,506 | $65.5K | $1.26M | 0.25% | +$1.19M |
| iBio, Inc.CON NEW(IBIO) | 600,000 | 570,000 | -30,000 | $2.19M | $1.20M | 0.24% | -$989.7K |
| Spero Therapeutics, Inc.(SPRO) | 926,929 | 918,929 | -8,000 | $1.59M | $1.19M | 0.24% | -$399.7K |
| Indivior Plc | 27,601 | 70,007 | +42,406 | $591.2K | $1.13M | 0.23% | +$537.3K |
| Pfizer Inc.(PFE) | 106,342 | 39,950 | -66,392 | $2.95M | $1.12M | 0.23% | -$1.83M |
| enVVeno Medical Corporation(NVNO) | 201,728 | 201,728 | 0 | $1.10M | $1.06M | 0.21% | -$38.3K |
| Target Hospitality Corp.(TH) | 0 | 113,626 | +113,626 | $0 | $989.7K | 0.20% | +$989.7K |
| Guardant Health, Inc.(GH) | 17,000 | 34,000 | +17,000 | $350.7K | $981.9K | 0.20% | +$631.2K |
| Vir Biotechnology, Inc.(VIR) | 0 | 110,000 | +110,000 | $0 | $979.0K | 0.20% | +$979.0K |
| Cullinan Therapeutics, Inc.(CGEM) | 0 | 53,261 | +53,261 | $0 | $928.9K | 0.19% | +$928.9K |
| Vaxcyte, Inc.(PCVX) | 2,000 | 12,250 | +10,250 | $136.6K | $925.0K | 0.19% | +$788.4K |
| Iteos Therapeutics Inc | 0 | 60,000 | +60,000 | $0 | $890.4K | 0.18% | +$890.4K |
| Alector Inc | 52,500 | 195,311 | +142,811 | $316.1K | $886.7K | 0.18% | +$570.7K |
| Denali Therapeutics Inc.(DNLI) | 2,000 | 38,000 | +36,000 | $41.0K | $882.4K | 0.18% | +$841.3K |
| AngioDynamics, Inc.(ANGO) | 153,362 | 143,862 | -9,500 | $900.2K | $870.4K | 0.18% | -$29.9K |
| Arvinas, Inc.(ARVN) | 26,200 | 32,400 | +6,200 | $1.08M | $862.5K | 0.17% | -$219.0K |
| Spyre Therapeutics, Inc.(SYRE) | 49,500 | 35,180 | -14,320 | $1.88M | $827.1K | 0.17% | -$1.05M |
| Avangrid Inc | 0 | 23,000 | +23,000 | $0 | $817.2K | 0.16% | +$817.2K |
| Keen Vision Acquisition CorporationUNIT 99 99 9999(KVACF) | 75,000 | 75,000 | 0 | $788.3K | $792.8K | 0.16% | +$4.5K |
| Apellis Pharmaceuticals Inc COM | 25,700 | 20,650 | -5,050 | $1.51M | $792.1K | 0.16% | -$718.5K |
| Silence Therapeutics plcADS(SLN) | 40,090 | 40,290 | +200 | $865.9K | $765.5K | 0.15% | -$100.4K |
| Kiora Pharmaceuticals, Inc.(KPRX) | 0 | 172,596 | +172,596 | $0 | $724.9K | 0.15% | +$724.9K |
| Sarepta Therapeutics, Inc.(SRPT) | 31,105 | 4,450 | -26,655 | $4.03M | $703.1K | 0.14% | -$3.32M |
| CytomX Therapeutics, Inc.(CTMX) | 155,000 | 572,170 | +417,170 | $337.9K | $698.0K | 0.14% | +$360.1K |
| Perspective Therapeutics, Inc.(CATX) | 0 | 69,985 | +69,985 | $0 | $697.8K | 0.14% | +$697.8K |
| Climb Bio, Inc.(CLYM) | 0 | 97,695 | +97,695 | $0 | $694.6K | 0.14% | +$694.6K |
| Beyond Air, Inc.(XAIR) | 1,204,820 | 1,225,270 | +20,450 | $2.10M | $658.3K | 0.13% | -$1.44M |
| Kezar Life Sciences Inc | 236,623 | 1,086,498 | +849,875 | $213.3K | $651.9K | 0.13% | +$438.6K |
| Vaxart, Inc.(VXRT) | 0 | 945,568 | +945,568 | $0 | $631.0K | 0.13% | +$631.0K |
| Corteva, Inc.(CTVA) | 37,400 | 11,400 | -26,000 | $2.16M | $614.9K | 0.12% | -$1.54M |
| Arya Sciences Acqu Corp IvCL A | 40,930 | 53,527 | +12,597 | $459.6K | $614.0K | 0.12% | +$154.3K |
| Akero Therapeutics Inc | 1,807 | 25,507 | +23,700 | $45.6K | $598.4K | 0.12% | +$552.7K |
| Taysha Gene Therapies, Inc.(TSHA) | 43,500 | 250,800 | +207,300 | $124.8K | $561.8K | 0.11% | +$436.9K |
| Actinium Pharmaceuticals, Inc.(ATNM) | 100,000 | 75,133 | -24,867 | $783.0K | $556.0K | 0.11% | -$227.0K |
| Tmt Acquisition CorpSHS | 50,000 | 50,000 | 0 | $534.5K | $549.0K | 0.11% | +$14.5K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 16,000 | 12,000 | -4,000 | $627.8K | $543.0K | 0.11% | -$84.8K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 12,400 | 13,000 | +600 | $537.3K | $533.8K | 0.11% | -$3.5K |
| Ardelyx Inc | 0 | 70,000 | +70,000 | $0 | $518.7K | 0.10% | +$518.7K |
| Ab Active Etfs IncULTRA SHORT INCM ULTRA SHORT INCM | 10,000 | 10,000 | 0 | $505.2K | $505.1K | 0.10% | -$50 |
| Pgim Etf TrPGIM ULTRA SH BD PGIM ULTRA SH BD | 10,000 | 10,000 | 0 | $497.0K | $497.0K | 0.10% | $0 |
| Stevanato Group S P A ORD SHS | 15,500 | 27,000 | +11,500 | $497.6K | $495.2K | 0.10% | -$2.4K |
| Day One Biopharmaceuticals I COM | 0 | 35,100 | +35,100 | $0 | $483.7K | 0.10% | +$483.7K |
| Gossamer Bio, Inc.(GOSS) | 732,628 | 532,628 | -200,000 | $864.5K | $479.8K | 0.10% | -$384.7K |
| Abeona Therapeutics Inc.(ABEO) | 0 | 113,125 | +113,125 | $0 | $479.6K | 0.10% | +$479.6K |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 180,145 | 1,850 | -178,295 | $26.92M | $449.6K | 0.09% | -$26.47M |
| PolyPid Ltd.(PYPD) | 0 | 103,950 | +103,950 | $0 | $447.0K | 0.09% | +$447.0K |
| SanofiADR(SNY) | 5,500 | 9,100 | +3,600 | $267.3K | $441.5K | 0.09% | +$174.2K |
| TherapeuticsMD, Inc.(TXMD) | 272,160 | 270,160 | -2,000 | $623.2K | $435.0K | 0.09% | -$188.3K |